Folate Study in Men With Advanced Prostate Cancer
Part of paid clinical trials in La Jolla, California.
- Sponsor
- University of California, San Diego
- Study ID
- NCT06536374
- Phase
- PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Trimethoprim Tablets — DRUGTrimethoprim 150mg is administered once daily for 3 months
Study Details
The researchers hope to learn if Trimethoprim, 150mg taken daily for 3 months, is a safe and effective way to reduce folate levels at time of Androgen Deprivation Therapy (ADT) in men with advanced prostate cancer. This study will help find out what effects, good and/or bad, this drug has on people who take it and on its effect on the disease. The safety of this drug in humans has been tested in prior research studies; however, some side effects may not yet be known.
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- Nov 2025
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Trimethoprim plus androgen deprivation therapyAdministration of trimethoprim to reduce folic acid levels at the time of standard of care androgen deprivation therapy.
- No Intervention: Standard of Care treatmentStandard of care treatment participants will have no intervention, only their prescribed androgen deprivation therapy.
Primary Outcome Measure
Safety of Trimethoprim [ Time Frame: From first dose of study therapy through 1 month after completion of study therapy. ]
Central Contacts
- Michael A Liss, MD, PhD(858) 822-5354
- Alexandrea Cronin(858) 822-5354
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Diego | La Jolla | California | 92093 |
Find similar trials in La Jolla, CA
Related Studies
- Active Surveillance for Cancer of the Prostate (ASCaP)Recruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
- SBRT Boost for Unfavorable Prostate Cancer'Recruiting · MemorialCare Health System · Fountain Valley, California
- Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate CancerEARLY_PHASE1 · Recruiting · Ivan de Kouchkovsky, MD · San Francisco, California
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPHASE2 · Recruiting · Astellas Pharma Global Development, Inc. · Anchorage, Alaska